218 related articles for article (PubMed ID: 29882690)
1. Immunotherapy combinations emerging in non-small-cell lung cancer.
Chao YL; Pecot CV
Immunotherapy; 2018 Jun; 10(8):627-629. PubMed ID: 29882690
[No Abstract] [Full Text] [Related]
2. The use of combination immunotherapies as front-line therapy for non-small-cell lung cancer.
Santana-Davila R; Chow LQ
Future Oncol; 2018 Feb; 14(3):191-194. PubMed ID: 29334785
[No Abstract] [Full Text] [Related]
3. Chemo-immunotherapy: The Beginning of a New Era in Lung Cancer.
Uprety D
Clin Lung Cancer; 2019 Mar; 20(2):63-65. PubMed ID: 30545572
[No Abstract] [Full Text] [Related]
4. Recent clinical trials of immunotherapy in non-small-cell lung cancer.
Gkolfinopoulos S; Mountzios G
Immunotherapy; 2019 Apr; 11(6):461-466. PubMed ID: 30860438
[No Abstract] [Full Text] [Related]
5. Non-small-cell lung cancer: what are the benefits and challenges of treating it with immune checkpoint inhibitors?
Rassy E; Mezquita L; Remon J; Besse B
Immunotherapy; 2019 Sep; 11(13):1149-1160. PubMed ID: 31361172
[TBL] [Abstract][Full Text] [Related]
6. [The role of immune checkpoint inhibitors in lung cancer: from clinical trials to clinical practice].
Wang ZM; Song Y
Zhonghua Jie He He Hu Xi Za Zhi; 2020 Feb; 43(2):95-99. PubMed ID: 32062879
[TBL] [Abstract][Full Text] [Related]
7. A banner year for immunotherapy and targeted therapy.
Carlisle JW; Ramalingam SS
Nat Rev Clin Oncol; 2019 Feb; 16(2):79-80. PubMed ID: 30538305
[No Abstract] [Full Text] [Related]
8. The New Immunotherapy Combinations in the Treatment of Advanced Non-Small Cell Lung Cancer: Reality and Perspectives.
Rocco D; Gravara LD; Gridelli C
Curr Clin Pharmacol; 2020; 15(1):11-19. PubMed ID: 31400270
[TBL] [Abstract][Full Text] [Related]
9. Advances in evidence-based medicine for immunotherapy of non-small cell lung cancer.
Dong J; Li B; Zhou Q; Huang D
J Evid Based Med; 2018 Nov; 11(4):278-287. PubMed ID: 30444051
[TBL] [Abstract][Full Text] [Related]
10. [Data from the AACR 2018 meeting on the combination chimio-immunotherapy on advanced non-small cells lung cancer (NSCLC)].
Simonneau Y; Ruppert AM; Chaabane N; Lavolé A; Wislez M
Bull Cancer; 2018 Oct; 105(10):854-856. PubMed ID: 30262415
[No Abstract] [Full Text] [Related]
11. Anti PD-L1 combined with other agents in non-small cell lung cancer: combinations with non-immuno-oncology agents.
Puri S; Chatwal M; Gray JE
Expert Rev Respir Med; 2017 Oct; 11(10):791-805. PubMed ID: 28786318
[TBL] [Abstract][Full Text] [Related]
12. Perioperative considerations for neoadjuvant immunotherapy in non-small cell lung cancer.
Stiles BM; Sepesi B; Broderick SR; Bott MJ
J Thorac Cardiovasc Surg; 2020 Nov; 160(5):1376-1382. PubMed ID: 32763029
[No Abstract] [Full Text] [Related]
13. [Predictive biomarkers for immune checkpoint inhibitors in non-small-cell lung cancer].
Fu MJ; Zhou JY
Zhonghua Jie He He Hu Xi Za Zhi; 2020 Feb; 43(2):87-91. PubMed ID: 32062877
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy for non-small cell lung cancer.
Vafadar S
JAAPA; 2019 Sep; 32(9):37-42. PubMed ID: 31460972
[TBL] [Abstract][Full Text] [Related]
15. [Non-small cell lung cancer].
Skřičková J; Kadlec B; Venclíček O
Vnitr Lek; 2018; 63(11):861-874. PubMed ID: 29303290
[TBL] [Abstract][Full Text] [Related]
16. Immune checkpoint inhibitors and non-small-cell lung cancer management: 2018 update.
Abdel-Rahman O; Morris D
Immunotherapy; 2019 Feb; 11(3):149-153. PubMed ID: 30730273
[No Abstract] [Full Text] [Related]
17. The Lingering Questions in Immunotherapy.
Wright K
Oncology (Williston Park); 2020 Mar; 34(3):. PubMed ID: 32212135
[No Abstract] [Full Text] [Related]
18. NCCN Guidelines Updates: New Immunotherapy Strategies for Improving Outcomes in Non-Small Cell Lung Cancer.
Gubens MA; Davies M
J Natl Compr Canc Netw; 2019 May; 17(5.5):574-578. PubMed ID: 31117034
[TBL] [Abstract][Full Text] [Related]
19. Treatment of N2 non-small cell lung cancer (NSCLC).
Klastersky J; Feld R; Kleisbauer JP; Rocmans P
Chest; 1989 Jul; 96(1 Suppl):83S-85S. PubMed ID: 2544376
[No Abstract] [Full Text] [Related]
20. Hepatic Intra-Arterial Chemotherapy With Immunotherapy in NSCLC.
Benitez JC; Mezquita L; Colle R; Tselikas L; Botticella A; Caramella C; Besse B
J Thorac Oncol; 2019 Oct; 14(10):e215-e216. PubMed ID: 31302233
[No Abstract] [Full Text] [Related]
[Next] [New Search]
